Search

Corvus Pharmaceuticals Inc

Atidarymo kaina

13.08 1

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

12.63

Max

13.14

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-1.4M

-14M

Pelnas, tenkantis vienai akcijai

-0.15

Darbuotojai

37

EBITDA

312K

-12M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+144.02% upside

Dividendai

By Acuity

Kitas uždarbis

2026-08-06

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-266M

1.1B

Ankstesnė atidarymo kaina

12.08

Ankstesnė uždarymo kaina

13.08

Corvus Pharmaceuticals Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-06-24 23:56; UTC

Correlated Moves

NXP Semiconductors NV shares are higher in after-market trading, supported by positive momentum in the semiconductor sector and a significant rise in SOXL.

2026-06-24 23:56; UTC

Correlated Moves

Intuit Inc. shares declined in after-market hours, following a broader market drop. The stock remains near the lower end of its one-month range.

2026-06-24 23:56; UTC

Correlated Moves

Autodesk Inc shares are lower in after-market trading, reflecting broader market declines. The stock remains near the lower end of its one-month range.

2026-06-24 23:56; UTC

Correlated Moves

Cadence Design Systems Inc shares gained in after-market trading, reflecting a slight uptick since Wednesday's close amid broader positive trends in correlated assets.

2026-06-24 23:56; UTC

News
Correlated Moves

Ethereum is trading lower during Wednesday's session, reflecting broader market trends as Bitcoin also declines. The cryptocurrency remains below its 20-day moving average.

2026-06-24 23:56; UTC

Correlated Moves

Cardano is lower during Wednesday's session, reflecting broader market sentiment amid Bitcoin's decline. The asset remains near the lower end of its one-month range.

2026-06-24 23:52; UTC

Correlated Moves
Social Media

NVIDIA shares are higher in after-market trading amid mixed social media sentiments and increased call options, reflecting bullish interest despite concerns over sector performance.

2026-06-24 23:52; UTC

News
Correlated Moves
Social Media

Applied Materials shares rose in after-market trading, boosted by strong earnings from Micron Technology and positive sentiment in the semiconductor sector.

2026-06-24 23:52; UTC

News
Correlated Moves

Lam Research Corp shares rise in after-market trading, driven by positive sentiment from Micron Technology's strong results and broader semiconductor sector gains.

2026-06-24 23:51; UTC

Mexican Business Confidence Remains Low at 47.5, Raising Concerns Ahead of July Survey Amidst Economic Challenges

2026-06-24 23:51; UTC

Adobe Inc shares are trading lower in after-market hours. No specific company news was identified to explain the movement.

2026-06-24 23:51; UTC

ETF Constituents

The Vanguard FTSE Emerging Markets ETF rose during after-market hours, bolstered by gains from Taiwan Semiconductor Manufacturing Company and United Microelectronics Corporation.

2026-06-24 23:51; UTC

Correlated Moves
Social Media

Apple Inc. shares are lower in after-market trading, dropping to the lower end of their one-month range amid increased options activity and a declining S&P 500 Index.

2026-06-24 23:51; UTC

O'Reilly Automotive shares declined in after-market trading, reflecting unusual weakness and positioning the stock below its 20-day moving average.

2026-06-24 23:51; UTC

Kraft Heinz Co shares are lower in after-market hours, continuing a weak performance trend. The stock remains near the lower end of its one-month range.

2026-06-24 23:51; UTC

Baidu Inc is rising in after-market trading, reflecting broader market gains amid easing geopolitical tensions and positive Federal Reserve assessments on large banks' resilience.

2026-06-24 23:51; UTC

Correlated Moves

Microchip Technology Inc is rising in after-market trading, buoyed by strong gains in the semiconductor sector and positive investor sentiment following the Fed's stress test results.

2026-06-24 23:51; UTC

JD.Com Inc. shares are higher in after-market hours, reflecting positive broader market trends. No specific company news was identified to explain the movement.

2026-06-24 23:51; UTC

Costco Wholesale Corp shares are lower in after-market trading. The stock remains below its 20-day moving average amid mixed market performance.

2026-06-24 23:51; UTC

Macro News
Correlated Moves

Bitcoin is under pressure as miners face margin squeezes, with revenue falling below production costs. Broader market volatility also contributes to the decline.

2026-06-24 23:51; UTC

Take-Two Interactive is advancing in after-market trading, reflecting broader market gains amid positive sentiment from favorable Federal Reserve stress test results.

2026-06-24 23:46; UTC

NetEase Inc shares rose in after-market trading, moving from a low of 0.35% to a high of 0.60%. No specific news was identified.

2026-06-24 23:41; UTC

South Korea's Exports Expected to Continue Strong Growth Ahead of July 1 Release, Following May Surge of 53.2% Year-on-Year

2026-06-24 23:41; UTC

Mixed market expectations ahead of July 1 release of MBA Mortgage Rate, with recent trends showing slight declines in rates and increased mortgage applications amid inflationary pressures.

2026-06-24 23:41; UTC

ETF Constituents

Vanguard FTSE Developed Markets ETF rises in after-market trading, supported by strong performances from holdings including TM, BHP, and AZN.

2026-06-24 23:41; UTC

News

The iShares Core U.S. Aggregate Bond ETF is trading lower in after-market hours, following a session marked by declines and mixed global market dynamics.

2026-06-24 23:41; UTC

ETF Constituents
Social Media

SPDR S&P 500 ETF Trust trades higher in after-market hours, buoyed by strong performances from Qualcomm and Micron Technology amid significant dark pool activity.

2026-06-24 23:41; UTC

News
Correlated Moves

Alphabet Inc. shares are lower in after-market hours, down $1.13 to about $345.00, amid a broader decline in the Interactive Media & Services sector.

2026-06-24 23:41; UTC

Correlated Moves

Alphabet Inc. shares are lower in after-market hours, impacted by a downturn in the Interactive Media & Services sub-sector and broader market declines.

2026-06-24 23:41; UTC

Event
News

Trip.com Group Ltd's stock is lower in after-market trading following a first-quarter net income decline and reduced second-quarter revenue guidance.

Akcijų palyginimas

Kainos pokytis

Corvus Pharmaceuticals Inc Prognozė

Kainos tikslas

By TipRanks

144.02% į viršų

12 mėnesių prognozė

Vidutinis 31.6 USD  144.02%

Aukščiausias 40 USD

Žemiausias 27 USD

Remiantis 5 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Corvus Pharmaceuticals Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

5 ratings

5

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immune modulator product candidates to treat solid cancers, T cell lymphomas, autoimmune, allergic, and infectious diseases. Its lead product candidate is soquelitinib (CPI-818), a selective covalent inhibitor of interleukin 2 inducible T cell kinase (ITK), which is in a multi-center Phase 1/1b clinical trial for the treatment of peripheral T cell lymphoma, solid tumors, and atopic dermatitis. The company is also developing ciforadenant (CPI-444), an oral small molecule antagonist of the A2A receptor that is in Phase 2 clinical trial for the treatment of metastatic renal cell cancer; and mupadolimab (CPI-006), a humanized monoclonal antibody, which is in Phase 1b clinical trial for the treatment of non-small cell lung cancer and head and neck cancer. In addition, it is developing CPI-182, an antibody designed to block inflammation and myeloid suppression that is in investigational new drug application-enabling studies, as well as CPI-935, an adenosine A2B receptor antagonist to prevent fibrosis. Corvus Pharmaceuticals, Inc. has a license afreemnt with Monash University to research, develop, and commercialize certain antibodies directed to CXCR2 for the treatment of human diseases; and Vernalis (R&D) Limited to develop, manufacture, and commercialize products containing certain adenosine receptor antagonists, including ciforadenant, as well as strategic collaboration with Angel Pharmaceuticals Co. Ltd. for the development and commercialization of mupadolimab. Corvus Pharmaceuticals, Inc. was incorporated in 2014 and is based in Burlingame, California.
help-icon Live chat